From: Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
 |  | Univariate | Multivariate | ||
---|---|---|---|---|---|
 |  | Median |  | ||
Variable | No. | survival | p-Value | HR (95% CI) | p-Value |
BWLa | |||||
 < 10% | 28 | N.R. |  |  |  |
 ≥ 10% | 26 | 46 | 0.163 |  | N.S. |
Postoperative diarrhea | |||||
 No | 34 | 40 |  |  |  |
 Yes | 20 | 21 | 0.379 |  | N.S. |
Extended dissection of nerve plexus around SMAb | |||||
 No | 39 | 67 |  |  |  |
 Yes | 15 | 22 | 0.011 | 3.289 (1.269–8.547) | 0.014 |
Residual tumor | |||||
 R0 | 47 | 53 |  |  |  |
 R1 | 7 | 28 | 0.095 | 4.236 (1.336–13.42) | 0.014 |
Lymph node metastasis | |||||
 Negative | 20 | 67 |  |  |  |
 Positive | 34 | 40 | 0.051 |  | N.S. |
AJCC Stage | |||||
 Stage IA, IB |  | 7 | N.R. |  |  |
 Stage IIA or higher | 47 | 28 | 0.026 |  | N.S. |
RDI in adjuvant chemotherapy | |||||
 ≥ 80% | 11 | N.R. |  |  |  |
 < 80% | 43 | 46 | 0.045 | 4.437 (1.437–13.70) | 0.010 |